Stifel Downgrades Alector Inc. (ALEC) to Hold

Stifel analyst Paul Mattels downgraded Alector Inc. (NASDAQ: ALEC) from Buy to Hold with a price target of $4.00.

The analyst comments "Within our Biotechnology Outlook, we discuss the key controversies for all 26 stocks in our coverage universe, and we lay out key questions for management teams during 1Q investor conferences. Within we delve into various topical investment debates impacting BMRN, BIIB, NMRA, DYN, CTNM, NGNE, and DNLI. We also preview 2025 revenues for our commercial companies, as NBIX, ACAD, ALNY, VRTX, KALV and IONS approach important launch inflection points. Lastly, within we outline thoughts/scenarios for clinical catalysts from ALKS, LXEO, PEPG, VIGL, ANRO, XENE, RAPP, GHRS, VTGN, and multiple others. More broadly, as part of this report we've refreshed our diligence on many companies within our coverage universe, and from this work we are downgrading BIIB (Hold) and ALEC (Hold), and we're upgrading DNLI to Buy."

For an analyst ratings summary and ratings history on Alector Inc. click here. For more ratings news on Alector Inc. click here.

Shares of Alector Inc. closed at $1.97 yesterday.

You May Also Be Interested In

• Correction: Kepler Cheuvreux Upgrades Siemens AG (SIE:GR) (SIEGY) to Hold
• Deutsche Bank Resumes Kloeckner & Co SE (KCO:GR) at Hold
• HSBC Upgrades Power Asset Holdings (6:HK) (HGKGF) to Buy